Our study identified that DDR2 is a novel regulator of EMT via DDR2-induced ERK2/SNAIL1 signaling activation, indicating its potential therapeutic value for reducing HCC invasion and metastasis. This evidence concerns the gene DDR2 and hepatocellular carcinoma.